ResearcherMoffitt Cancer CenterNo recent work listed

Kate M. Bailey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8554-9809; OpenAlex author ID A5101736863. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2014: 1 paper

Papers 1

Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0113586 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert J. Gillies · 1 shared paper, 2014 · strength 0.04
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586 ↗
Pawel Swietach · 1 shared paper, 2014 · strength 0.04
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586 ↗
Amanda F. Baker · 1 shared paper, 2014 · strength 0.04
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586 ↗
Xiaomeng Zhang · 1 shared paper, 2014 · strength 0.04
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586 ↗
Charles P. Hart · 1 shared paper, 2014 · strength 0.04
- Paper Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. DOI 10.1371/journal.pone.0113586 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.